Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy

被引:11
作者
Paiss, T
Herkommer, K
Bock, B
Heinz, H
Vogel, W
Kron, M
Kuefer, R
Hautmann, RE
Gschwend, JE
机构
[1] Univ Ulm, Dept Urol & Paediat Urol, D-89075 Ulm, Germany
[2] Univ Ulm, Dept Human Genet, D-89075 Ulm, Germany
[3] Univ Ulm, Dept Biometry & Med Documentat, D-89075 Ulm, Germany
关键词
prostate cancer; familial; hereditary; clinical; epidemiological;
D O I
10.1016/S0302-2838(03)00146-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: We evaluated if epidemiological features of familial prostate cancer are associated with certain clinical or histopathological characteristics of the disease. Methods: 463 German patients with familial prostate cancer who underwent radical prostatectomy were stratified according to several epidemiological criteria: (1) the apparent mode of disease transmission, (2) the average age of onset and (3) number of affected relatives/family, (4) whether or not they met the Johns Hopkins criteria of hereditary prostate cancer. The variables analysed included the Prostate Specific Antigen (PSA) and the digital rectal examination at diagnosis, histopathological characteristics of the prostatectomy specimen and relapse free 5-year survival rates. These characteristics were compared within the subsets of familial patients and compared to 492 control patients with sporadic prostate cancer. Results: Age of onset was the only clinical parameter differentiating familial and sporadic prostate cancer. Otherwise there was no association between epidemiological features of familial predisposition and the clinical presentation or outcome of the disease. Conclusions: Familial and sporadic prostate cancer seem to be the same disease. Alternatively it may be concluded that the common epidemiological features of familial prostate cancer are not useful to tell tumours that are based on inherited susceptibility apart from those that are not. Whether hereditary prostate cancer is clinically distinct from sporadic forms cannot be determined before the underlying genetic alterations are identified. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 34 条
[1]  
[Anonymous], 1997, AJCC CANC STAGING MA
[2]   PATHOLOGICAL FEATURES OF HEREDITARY PROSTATE-CANCER [J].
BASTACKY, SI ;
WOJNO, KJ ;
WALSH, PC ;
CARMICHAEL, MJ ;
EPSTEIN, JI .
JOURNAL OF UROLOGY, 1995, 153 (03) :987-992
[3]   Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy [J].
Bauer, JJ ;
Srivastava, S ;
Connelly, RR ;
Sesterhenn, IA ;
Preston, DM ;
McLeod, DG ;
Moul, JW .
UROLOGY, 1998, 51 (06) :970-976
[4]   Evidence for a prostate cancer-susceptibillty locus on chromosome 20 [J].
Berry, R ;
Schroeder, JJ ;
French, AJ ;
McDonnell, SK ;
Peterson, BJ ;
Cunningham, JM ;
Thibodeau, SN ;
Schaid, DJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (01) :82-91
[5]   Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43 [J].
Berthon, P ;
Valeri, A ;
Cohen-Akenine, A ;
Drelon, E ;
Paiss, T ;
Wöhr, G ;
Latil, A ;
Millasseau, P ;
Mellah, I ;
Cohen, N ;
Blanché, H ;
Bellané-Chantelot, C ;
Demenais, F ;
Teillac, P ;
Le Duc, A ;
de Petriconi, R ;
Hautmann, R ;
Chumakov, I ;
Bachner, L ;
Maitland, NJ ;
Lidereau, R ;
Vogel, W ;
Fournier, G ;
Mangin, P ;
Cohen, D ;
Cussenot, O .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) :1416-1424
[6]   Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families [J].
Bochum, S ;
Paiss, T ;
Vogel, W ;
Herkommer, K ;
Hautmann, R ;
Haeussler, J .
PROSTATE, 2002, 52 (01) :12-19
[7]   Hereditary prostate cancer:: Clinical characteristics and survival [J].
Bratt, O ;
Damber, JE ;
Emanuelsson, M ;
Grönberg, H .
JOURNAL OF UROLOGY, 2002, 167 (06) :2423-2426
[8]   Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 [J].
Carpten, J ;
Nupponen, N ;
Isaacs, S ;
Sood, R ;
Robbins, C ;
Xu, J ;
Faruque, M ;
Moses, T ;
Ewing, C ;
Gillanders, E ;
Hu, P ;
Buinovszky, P ;
Makalowska, I ;
Baffoe-Bonnie, A ;
Faith, D ;
Smith, J ;
Stephan, D ;
Wiley, K ;
Brownstein, M ;
Gildea, D ;
Kelly, B ;
Jenkins, R ;
Hostetter, G ;
Matikainen, M ;
Schleutker, J ;
Klinger, K ;
Connors, T ;
Xiang, Y ;
Wang, Z ;
De Marzo, A ;
Papadopoulos, N ;
Kallioniemi, OP ;
Burk, R ;
Meyers, D ;
Grönberg, H ;
Meltzer, P ;
Silverman, R ;
Bailey-Wilson, J ;
Walsh, P ;
Isaacs, W ;
Trent, J .
NATURE GENETICS, 2002, 30 (02) :181-184
[9]   HEREDITARY PROSTATE-CANCER - EPIDEMIOLOGIC AND CLINICAL-FEATURES [J].
CARTER, BS ;
BOVA, GS ;
BEATY, TH ;
STEINBERG, GD ;
CHILDS, B ;
ISAACS, WB ;
WALSH, PC .
JOURNAL OF UROLOGY, 1993, 150 (03) :797-802
[10]   Segregation analyses of 1,476 population-based Australian families affected by prostate cancer [J].
Cui, JS ;
Staples, MP ;
Hopper, JL ;
English, DR ;
McCredie, MRE ;
Giles, GG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (05) :1207-1218